The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia.
about
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy.
P2860
The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The utility of serum prostatic ...... benign prostatic hyperplasia.
@en
The utility of serum prostatic ...... benign prostatic hyperplasia.
@nl
type
label
The utility of serum prostatic ...... benign prostatic hyperplasia.
@en
The utility of serum prostatic ...... benign prostatic hyperplasia.
@nl
prefLabel
The utility of serum prostatic ...... benign prostatic hyperplasia.
@en
The utility of serum prostatic ...... benign prostatic hyperplasia.
@nl
P2860
P356
P1476
The utility of serum prostatic ...... benign prostatic hyperplasia.
@en
P2093
C G Roehrborn
P2860
P2888
P304
P356
10.1038/IJIR.2008.53
P478
20 Suppl 3
P577
2008-12-01T00:00:00Z
P5875
P6179
1039179052